Translate
Summit Therapeutics Inc.
About
17.46USD+0.09 +0.55%
Closed • Updated at 18:56 GMT+00:00Market Cap$13.55B
Volume2.97M
Beta1.94
RSI46.21
Summit Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026
Mar 27 2026
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
Feb 23 2026
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025
Feb 17 2026
Summit Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results & Operational Progress Call on February 23, 2026
Jan 29 2026
Summit Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) Seeking Approval for Ivonescimab in Combination with Chemotherapy in Treatment of Patients with EGFRm NSCLC Post-TKI Therapy
Recent Videos
Why Is Summit Therapeutics Inc. Stock Suddenly Up 13%?
May 21, 2026
SMMT STOCK : NEXT BIG SWING | SUMMIT THERAPEUTICS STOCK
May 18, 2026
05 Mayo 26. Noticias acciones biotecnológicas. Resumen diario. Análisis SUMMIT SMMT XBI #biotechnews
May 05, 2026
Why Summit Therapeutics Stock will Pump Investors Wealth? SMMT STOCK ANALYSIS
May 01, 2026
Community Chat
Ask AI
Try asking